Home

search

current Issue

archive

Site help

 
 
Click here to subscribe

 

GGH at a glance

Editorial Board

Contact Us

Subscribe

Online Resources

PDF Reader

Announcements

GH Guidelines

Figure

Extended Life-Span Conferred by Cotransporter Gene Mutations in Drosophila

Volume 18, Issue 1, 2002
 

 
Life-span extension in Indy mutants. Survival curves of males heterozygous for three different Indy mutations, a precise excision of the P -element from Indy 302 (revertant), and an enhancer-trap control are shown. All flies were tested as heterozygotes over a wild-type Canton-S strain. The Indy mutants are Indy302 (open green circles), Indy206 (solid blue circles), and Indy159 (open orange circles). The excision line (open red squares) is one of four exact excisions (sequence confirmed) of the P element obtained by mobilizing the P element from either the Indy302 or Indy206 line, using delta 2-3 transposase. The control (solid black squares) is one of four other enhancertrap control lines from the same mutagenesis that generated Indy302 and Indy206, tested as a heterozygote over Canton-S. A similar control survival curve was found for a control from the mutagenesis that gave rise to Indy159. The mean 25°C life-spans of controls were 37 days, whereas the mean life-spans for Indy206, Indy302, and Indy159 were 71, 69, and 69 days, respectively. Indy206, Indy302, and Indy159 extended mean life-span by 92, 87, and 87% respectively. Extension of 1% maximal life-span of these Indy mutants was greater than 45%. At 18°C, the increase in mean life-span conferred by Indy mutations approached 100%, whereas the increase in 1% maximum life-span approached 50%. Flies were maintained in a humidified, temperature-controlled environmental chamber at 25°C and were transferred to fresh food vials and scored for survival every 2 to 3 days as in. Each survivorship curve represents data from over 300 male flies. A total of 5430 male and female Indy heterozygote flies were tested.
 
Rogina B, et al.  Science 290:2137-2140, 2000.
 
Back to article
 

Home | Search | Current Issue | Archive | Site Help

GGH at a Glance | Editorial Board | Contact Us | Subscribe | Announcements

Online Resources | PDF Reader | Genentech, Inc. | Prime Health Consultants, Inc.

Copyright ©2003 Prime Health Consultants, Inc.